Literature DB >> 20200288

Longitudinal genotyping of Candida dubliniensis isolates reveals strain maintenance, microevolution, and the emergence of itraconazole resistance.

M Fleischhacker1, J Pasligh, G Moran, M Ruhnke.   

Abstract

We investigated the population structure of 208 Candida dubliniensis isolates obtained from 29 patients (25 human immunodeficiency virus [HIV] positive and 4 HIV negative) as part of a longitudinal study. The isolates were identified as C. dubliniensis by arbitrarily primed PCR (AP-PCR) and then genotyped using the Cd25 probe specific for C. dubliniensis. The majority of the isolates (55 of 58) were unique to individual patients, and more than one genotype was recovered from 15 of 29 patients. A total of 21 HIV-positive patients were sampled on more than one occasion (2 to 36 times). Sequential isolates recovered from these patients were all closely related, as demonstrated by hybridization with Cd25 and genotyping by PCR. Six patients were colonized by the same genotype of C. dubliniensis on repeated sampling, while strains exhibiting altered genotypes were recovered from 15 of 21 patients. The majority of these isolates demonstrated minor genetic alterations, i.e., microevolution, while one patient acquired an unrelated strain. The C. dubliniensis strains could not be separated into genetically distinct groups based on patient viral load, CD4 cell count, or oropharyngeal candidosis. However, C. dubliniensis isolates obtained from HIV-positive patients were more closely related than those recovered from HIV-negative patients. Approximately 8% (16 of 194) of isolates exhibited itraconazole resistance. Cross-resistance to fluconazole was only observed in one of these patients. Two patients harboring itraconazole-resistant isolates had not received any previous azole therapy. In conclusion, longitudinal genotyping of C. dubliniensis isolates from HIV-infected patients reveals that isolates from the same patient are generally closely related and may undergo microevolution. In addition, isolates may acquire itraconazole resistance, even in the absence of prior azole therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200288      PMCID: PMC2863881          DOI: 10.1128/JCM.01522-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

Authors:  M Ruhnke; A Schmidt-Westhausen; J Morschhäuser
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

3.  Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.

Authors:  M A Jabra-Rizk; W A Falkler; W G Merz; A A Baqui; J I Kelley; T F Meiller
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.

Authors:  Sarah F Gee; Sophie Joly; David R Soll; Jacques F G M Meis; Paul E Verweij; Itzhack Polacheck; Derek J Sullivan; David C Coleman
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

5.  'Genotypic shuffling' of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis.

Authors:  Y H Samaranayake; L P Samaranayake; R S Dassanayake; J Y Y Yau; W K Tsang; B P K Cheung; K W S Yeung
Journal:  J Med Microbiol       Date:  2003-04       Impact factor: 2.472

6.  Tissue-associated cytokine expression in HIV-positive persons with oropharyngeal candidiasis.

Authors:  Elizabeth A Lilly; Darrenn J Hart; Janet E Leigh; Shannon Hager; Kelly M McNulty; Donald E Mercante; Paul L Fidel
Journal:  J Infect Dis       Date:  2004-06-25       Impact factor: 5.226

7.  Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.

Authors:  Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Molecular mechanisms of itraconazole resistance in Candida dubliniensis.

Authors:  Emmanuelle Pinjon; Gary P Moran; Colin J Jackson; Steven L Kelly; Dominique Sanglard; David C Coleman; Derek J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.

Authors:  Gary Moran; Derek Sullivan; Joachim Morschhäuser; David Coleman
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

10.  Multilocus sequence typing reveals that the population structure of Candida dubliniensis is significantly less divergent than that of Candida albicans.

Authors:  Brenda A McManus; David C Coleman; Gary Moran; Emmanuelle Pinjon; Dorothée Diogo; Marie-Elisabeth Bougnoux; Silvia Borecká-Melkusova; Helena Bujdákova; Philip Murphy; Christophe d'Enfert; Derek J Sullivan
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

View more
  3 in total

1.  In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

Authors:  Arjuna Nishantha Bandara Ellepola; Ranil Samantha Dassanayake; Ziauddin Khan
Journal:  Med Princ Pract       Date:  2019-06-28       Impact factor: 1.927

2.  In vitro Impact of Limited Exposure to Subtherapeutic Concentrations of Chlorhexidine Gluconate on the Adhesion-Associated Attributes of Oral Candida Species.

Authors:  Arjuna N B Ellepola; Rachel Chandy; Zia U Khan
Journal:  Med Princ Pract       Date:  2016-04-23       Impact factor: 1.927

3.  Performance comparison of phenotypic and molecular methods for detection and differentiation of Candida albicans and Candida dubliniensis.

Authors:  Suhail Ahmad; Ziauddin Khan; Mohammad Asadzadeh; Ajmal Theyyathel; Rachel Chandy
Journal:  BMC Infect Dis       Date:  2012-09-25       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.